Literature DB >> 10089827

Receptor-mediated targeting of phthalocyanines to macrophages via covalent coupling to native or maleylated bovine serum albumin.

N Brasseur1, R Langlois, C La Madeleine, R Ouellet, J E van Lier.   

Abstract

Targeted delivery of aluminum tetrasulfophthalocyanine (AlPcS4) to the scavenger receptor of macrophages, via coupling to maleylated bovine serum albumin (mal-BSA), was explored as a means to improve photodynamic efficacy. The AlPcS4 was covalently coupled to BSA (9:1 molar ratio) via one or two sulfonamide-hexanoic-amide spacer chains, followed by treatment with maleic anhydride to yield the mal-BSA-phthalocyanine conjugates. The latter were tested for singlet oxygen production, receptor-mediated cell uptake and phototoxicity toward J774 cells of macrophage origin and nonphagocytic EMT-6 cells. Cell uptake of 125I-mal-BSA showed specific binding for J774 cells but not for EMT-6 cells. Competition studies of the conjugates with 125I-mal-BSA showed that coupling of AlPcS4 to BSA resulted in recognition of the conjugate by the scavenger receptor, whereas coupling to mal-BSA further enhanced its binding affinity. This suggests that affinity for the scavenger receptor is related to the overall negative charge of the protein. Phototoxicity of the conjugates toward J774 cells paralleled their relative affinity, with mal-BSA-AlPcS4 coupled via two spacer chains showing the highest activity. The conjugates were less phototoxic toward the EMT-6 cell line. The activities in both cell lines of all conjugated AlPcS4 preparations were, however, lower than that of the free disulfonated AlPcS2. Possible implications for the in vivo use of protein-photosensitizer conjugates to target selectively various macrophage-associated disorders is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10089827     DOI: 10.1562/0031-8655(1999)069<0345:rmtopt>2.3.co;2

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  9 in total

1.  TARGETING OF MACROPHAGE FOAM CELLS IN ATHEROSCLEROTIC PLAQUE USING OLIGONUCLEOTIDE-FUNCTIONALIZED NANOPARTICLES.

Authors:  Gaurav Sharma; Zhi-Gang She; David T Valenta; William B Stallcup; Jeffrey W Smith
Journal:  Nano Life       Date:  2010-09

Review 2.  Antibody-based imaging strategies for cancer.

Authors:  Jason M Warram; Esther de Boer; Anna G Sorace; Thomas K Chung; Hyunki Kim; Rick G Pleijhuis; Gooitzen M van Dam; Eben L Rosenthal
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

3.  Receptor-targeting phthalocyanine photosensitizer for improving antitumor photocytotoxicity.

Authors:  Peng Xu; Jincan Chen; Zhuo Chen; Shanyong Zhou; Ping Hu; Xueyuan Chen; Mingdong Huang
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

4.  Internalisation enhances photo-induced cytotoxicity of monoclonal antibody-phthalocyanine conjugates.

Authors:  M Carcenac; M Dorvillius; V Garambois; F Glaussel; C Larroque; R Langlois; N E Hynes; J E van Lier; A Pèlegrin
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640

5.  The development and characterisation of porphyrin isothiocyanate-monoclonal antibody conjugates for photoimmunotherapy.

Authors:  R Hudson; M Carcenac; K Smith; L Madden; O J Clarke; A Pèlegrin; J Greenman; R W Boyle
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

6.  Evaluation of the correlation between porphyrin accumulation in cancer cells and functional positions for application as a drug carrier.

Authors:  Koshi Nishida; Toshifumi Tojo; Takeshi Kondo; Makoto Yuasa
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

7.  Surface chemistry-mediated modulation of adsorbed albumin folding state specifies nanocarrier clearance by distinct macrophage subsets.

Authors:  Michael P Vincent; Sharan Bobbala; Nicholas B Karabin; Molly Frey; Yugang Liu; Justin O Navidzadeh; Trevor Stack; Evan A Scott
Journal:  Nat Commun       Date:  2021-01-28       Impact factor: 17.694

8.  A novel tumor targeting drug carrier for optical imaging and therapy.

Authors:  Rui Li; Ke Zheng; Ping Hu; Zhuo Chen; Shanyong Zhou; Jincan Chen; Cai Yuan; Song Chen; Wei Zheng; En Ma; Fengling Zhang; Jinping Xue; Xueyuan Chen; Mingdong Huang
Journal:  Theranostics       Date:  2014-03-24       Impact factor: 11.556

Review 9.  Porphyrin photosensitizers in photodynamic therapy and its applications.

Authors:  Jiayuan Kou; Dou Dou; Liming Yang
Journal:  Oncotarget       Date:  2017-08-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.